Molson Coors announces partnership with Fever-Tree in US
Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its premiumisation and ‘Beyond Beer’ strategies. Through the deal, Molson Coors will assume exclusive commercialisation rights to Fever-Tree’s range of tonics, ginger beers, cocktail mixers and more in the US, starting from 1 February 2025.
Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
TAP has also been making impressive innovations, especially in Beyond Beer. Molson Coors’ Acceleration Plan had been built upon the success accomplished under its Revitalization Plan implemented ...
Molson Coors’ Americas segment has faced significant challenges in 2024, driven by tough macroeconomic conditions in the U.S. beer industry ... offset by growth in Canadian brand volumes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback